FDA approves 1st iron IV treatment for heart failure patients

The FDA approved the first intravenous iron replacement therapy for adults with heart failure.

Injectafer, made by Daiichi Sankyo, is a ferric carboxymaltose injection treatment for iron deficiency in adult patients with heart failure to improve exercise capacity, according to a June 5 company news release. It has already been approved in 86 countries since 2007 and is the most extensively studied IV iron treatment.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars